In BMC Cancer this week, a team of researchers in China compare the usefulness of serum golgi protein 73 and alpha-fetoprotein as biomarkers for hepatocellular carcinoma. The team conducted a review of the available literature, and found that GP73 and AFP were of comparable accuracy, sensitivity, and specificity in diagnosing hepatocellular carcinoma. However, the researchers add, more study is needed to determine the diagnostic utility of GP73 in combination with AFP.
This Week in BMC Cancer
Premium
Get the full story with
GenomeWeb Premium
Only $95 for the
first 90 days*
GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives
Never miss another important industry story.
You may already have institutional access!
Already a GenomeWeb or 360Dx Premium member?
Login Now.
*Before your trial expires, we’ll put together a custom quote with your long-term premium options.
Not ready for premium?
Register for Free ContentYou can still register for access to our free content.